Prodrug

0 marketed 1 in Phase 3 1 in Phase 1

This page covers all Prodrug drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H+/K+ ATPase, AKR1C3.

Targets

H+/K+ ATPase · AKR1C3

Phase 3 pipeline (1)

TZP-101 · Tranzyme, Inc. · Gastrointestinal
TZP-101 is a prodrug that is converted into its active form, which is a potent inhibitor of gastric acid secretion.

Phase 1 pipeline (1)

AKR1C3-activated Prodrug AST-3424 · SWOG Cancer Research Network · Oncology
Activates AKR1C3